Key terms
About LFMD
LifeMD, Inc. is a telehealth company, which engages in offering a portfolio of direct-to-patient products and services. The firm combines virtual medical treatment with prescription medications and over-the-counter products. It operates through the Telehealth and WorkSimpli segments. The company was founded by Justin Schreiber on May 24, 1994 and is headquartered in New York, NY.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest LFMD news
Apr 18
4:55am ET
LifeMD management to meet with Craig-Hallum
Apr 16
8:40am ET
Analysts’ Top Healthcare Picks: Avid Bioservices (CDMO), LifeMD (LFMD)
Apr 16
4:55am ET
LifeMD management to meet with BTIG
Apr 12
1:16pm ET
LifeMD management to meet with Craig-Hallum
Apr 12
8:05am ET
Buy Rating Affirmed for LifeMD Amid Favorable Legal Outlook and Competitive Strengths
Apr 10
1:15pm ET
LifeMD management to meet with BTIG
Apr 09
9:10am ET
Analysts Offer Insights on Healthcare Companies: Alkermes (ALKS), LifeMD (LFMD) and Apyx Medical (APYX)
Apr 04
9:05am ET
Craig-Hallum Remains a Buy on LifeMD (LFMD)
Mar 26
8:45am ET
LifeMD (LFMD) Gets a Buy from Craig-Hallum
Mar 19
8:35am ET
LifeMD (LFMD) Receives a Buy from Craig-Hallum
Mar 15
7:10am ET
LifeMD price target raised to $13 from $11 at BTIG
Mar 12
8:43am ET
LifeMD price target raised to $15 from $10 at Craig-Hallum
Mar 12
8:30am ET
LifeMD price target raised to $12 from $11 at B. Riley
Mar 12
7:35am ET
LifeMD Poised for Growth: Strong Q4 Performance and Positive FY24 Outlook Reinforce Buy Rating
Mar 12
7:18am ET
LifeMD price target raised to $11 from $9 at Cantor Fitzgerald
Mar 12
6:27am ET
Robust Growth and Strategic Partnerships Reinforce Buy Rating for LifeMD
Mar 11
4:19pm ET
LifeMD sees FY24 revenue at least $200M , consensus $191.52M
Mar 11
4:17pm ET
LifeMD sees Q1 revenue $42 M- $43M , consensus $42.54M
Mar 11
4:16pm ET
LifeMD reports Q4 EPS 15c, consensus (14c)
Feb 26
9:05am ET
Craig-Hallum Gives a Buy Rating to LifeMD (LFMD)
Feb 21
8:46am ET
Craig-Hallum Reaffirms Their Buy Rating on LifeMD (LFMD)
Feb 21
8:37am ET
Medifast price target lowered to $40 from $67 at DA Davidson
Feb 16
9:05am ET
LifeMD (LFMD) Receives a Buy from Craig-Hallum
Feb 16
8:50am ET
Analysts Are Bullish on These Healthcare Stocks: LifeMD (LFMD), Tandem Diabetes Care (TNDM)
Jan 23
8:45am ET
Craig-Hallum Reaffirms Their Buy Rating on LifeMD (LFMD)
LFMD Financials
Key terms
Ad Feedback
LFMD Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
LFMD Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
